Five Prime's pipeline includes potentially first-in-class anti-FGFR2b antibody bemarituzumab
Move comes after recommendation from independent data and safety monitoring board
Country's Health Ministry also recommended extending gap between doses to 12 weeks
Novartis will aid manufacturing for up to 50 million doses of CureVac's vaccine in 2021
Late-stage trial results found vaccine gives 91.6% protection against COVID-19
The European Medicines Agency is also reviewing an application for the drug
Pfizer, Moderna and AstraZeneca are all working on modified vaccines
Company is hoping FDA will review data from a UK-based trial
Company can acquire asset following the completion of IND enabling studies
PME interviews Evoke's Executive Creative Director
PME interviews Makara Health's owner and managing director
PME interviews integrated medhealth communication (imc) group's President and CEO
Company has signed agreements to bolster vaccine manufacturing capacity
First COVAX shipments of vaccine dispatched to Ghana and Cote D’Ivoire
Data suggests vaccine is 80% effective at preventing hospitalisations in over-80s
Development and commercialisation deal could be worth up to $1.08bn
Checkpoint inhibitor gained accelerated approval in 2019
As Moderna expects COVID-19 vaccine sales to reach $18.4bn this year
Detailed results from the NAVIGATOR trial presented at virtual AAAAI meeting
New hires bolster market access, scientific and medical and creative capabilities
Newly established role creates new in-house speciality area at agency
Carucci initially joined McCann in February 2018 as medical director
Ahmadi joined Genmab in 2017, previously serving as senior vice president, head of oncology
Yost will replace Jennie Talman, who is stepping aside after 15 years
About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...